Masimo Debt to Equity Ratio 2007-2020 | MASI

Current and historical debt to equity ratio values for Masimo (MASI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Masimo debt/equity for the three months ending June 30, 2020 was 0.00.
Masimo Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2020-06-30 $0.00B $1.35B 0.00
2020-03-31 $0.00B $1.25B 0.00
2019-12-31 $0.00B $1.17B 0.00
2019-09-30 $0.00B $1.11B 0.00
2019-06-30 $0.00B $1.04B 0.00
2019-03-31 $0.00B $1.01B 0.00
2018-12-31 $0.00B $0.97B 0.00
2018-09-30 $0.00B $0.91B 0.00
2018-06-30 $0.00B $0.83B 0.00
2018-03-31 $0.00B $0.77B 0.00
2017-12-31 $0.00B $0.72B 0.00
2017-09-30 $0.00B $0.72B 0.00
2017-06-30 $0.00B $0.71B 0.00
2017-03-31 $0.00B $0.63B 0.00
2016-12-31 $0.00B $0.56B 0.00
2016-09-30 $0.15B $0.33B 0.46
2016-06-30 $0.18B $0.30B 0.59
2016-03-31 $0.23B $0.27B 0.84
2015-12-31 $0.19B $0.28B 0.67
2015-09-30 $0.19B $0.27B 0.71
2015-06-30 $0.18B $0.28B 0.63
2015-03-31 $0.13B $0.33B 0.39
2014-12-31 $0.13B $0.31B 0.41
2014-09-30 $0.00B $0.28B 0.00
2014-06-30 $0.00B $0.32B 0.00
2014-03-31 $0.00B $0.35B 0.00
2013-12-31 $0.00B $0.33B 0.00
2013-09-30 $0.00B $0.31B 0.00
2013-06-30 $0.00B $0.29B 0.00
2013-03-31 $0.00B $0.28B 0.00
2012-12-31 $0.00B $0.28B 0.00
2012-09-30 $0.00B $0.31B 0.00
2012-06-30 $0.00B $0.30B 0.00
2012-03-31 $0.00B $0.28B 0.00
2011-12-31 $0.00B $0.28B 0.00
2011-09-30 $0.00B $0.30B 0.00
2011-06-30 $0.00B $0.28B 0.00
2011-03-31 $0.00B $0.26B 0.00
2010-12-31 $0.00B $0.23B 0.00
2010-09-30 $0.00B $0.25B 0.00
2010-06-30 $0.00B $0.23B 0.00
2010-03-31 $0.00B $0.21B 0.00
2009-12-31 $0.00B $0.29B 0.00
2009-09-30 $0.00B $0.27B 0.00
2009-06-30 $0.00B $0.25B 0.00
2009-03-31 $0.00B $0.24B 0.00
2008-12-31 $0.00B $0.22B 0.00
2008-09-30 $0.00B $0.21B 0.00
2008-06-30 $0.00B $0.19B 0.00
2008-03-31 $0.00B $0.17B 0.00
2007-12-31 $0.02B $0.15B 0.13
2007-09-30 $0.02B $0.14B 0.16
2007-06-30 $0.03B $0.08B 0.32
2007-03-31 $0.00B 0.00
2006-09-30 $0.00B 0.00
2006-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.269B $0.938B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $169.728B 32.21
Intuitive Surgical (ISRG) United States $76.719B 68.93
Edwards Lifesciences (EW) United States $51.729B 46.22
DexCom (DXCM) United States $37.273B 128.49
IDEXX Laboratories (IDXX) United States $30.174B 67.06
ALCON INC (ALC) Switzerland $28.726B 51.17
Olympus (OCPNY) Japan $27.926B 72.75
Fresenius Medical Care AG KGaA (FMS) Germany $25.573B 16.49
Sysmex ADR (SSMXY) Japan $19.823B 65.96
Hologic (HOLX) United States $16.464B 24.64
Teleflex (TFX) United States $15.721B 31.01
Varian Medical Systems (VAR) United States $15.720B 43.22
SONOVA HOLDING (SONVY) Switzerland $15.629B 0.00
STERIS (STE) Ireland $14.962B 30.75
ABIOMED (ABMD) United States $11.941B 71.25
SARTORIUS AG (SARTF) Germany $11.366B 97.72
Penumbra (PEN) United States $7.437B 1211.65
Tandem Diabetes Care (TNDM) United States $6.480B 0.00
Elekta AB (EKTAY) Sweden $5.089B 39.18
Globus Medical (GMED) United States $5.000B 39.94
Nevro (NVRO) United States $4.890B 0.00
Wright Medical Group (WMGI) Netherlands $3.962B 0.00
Integra LifeSciences Holdings (IART) United States $3.929B 21.48
Nihon Kohden (NHNKY) Japan $2.684B 27.17
ShockWave Medical (SWAV) United States $2.460B 0.00
Silk Road Medical (SILK) United States $2.344B 0.00
LivaNova (LIVN) United Kingdom $2.176B 22.13
OPKO Health (OPK) United States $2.123B 0.00
Glaukos (GKOS) United States $2.095B 0.00
Integer Holdings (ITGR) United States $1.907B 14.45
Cantel Medical (CMD) United States $1.810B 25.87
Veracyte (VCYT) United States $1.655B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.619B 36.40
Pacific Biosciences Of California (PACB) United States $1.255B 0.00
Mesa Laboratories (MLAB) United States $1.253B 61.86
Luminex (LMNX) United States $1.172B 109.91
GenMark Diagnostics (GNMK) United States $0.968B 0.00
OrthoPediatrics (KIDS) United States $0.849B 0.00
Si-Bone (SIBN) United States $0.695B 0.00
CryoLife (CRY) United States $0.658B 289.67
Inogen (INGN) United States $0.635B 66.91
Accelerate Diagnostics (AXDX) United States $0.632B 0.00
Tactile Systems Technology (TCMD) United States $0.625B 536.83
Natus Medical (NTUS) United States $0.620B 25.06
Fluidigm (FLDM) United States $0.583B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.577B 71.07
Intersect ENT (XENT) United States $0.574B 0.00
AxoGen (AXGN) United States $0.526B 0.00
ViewRay (VRAY) United States $0.470B 0.00
Quotient (QTNT) Switzerland $0.456B 0.00
TransMedics (TMDX) United States $0.427B 0.00
Alphatec Holdings (ATEC) United States $0.397B 0.00
SeaSpine Holdings (SPNE) United States $0.386B 0.00
AngioDynamics (ANGO) United States $0.378B 110.78
Semler Scientific (SMLR) United States $0.345B 44.12
Repro Med Systems (KRMD) United States $0.335B 152.60
Oxford Immunotec Global (OXFD) United Kingdom $0.334B 0.00
Vermillion (AWH) United States $0.298B 0.00
IRadimed (IRMD) United States $0.273B 51.86
Accuray (ARAY) United States $0.242B 0.00
Sientra (SIEN) United States $0.189B 0.00
T2 Biosystems (TTOO) United States $0.185B 0.00
DarioHealth (DRIO) Israel $0.159B 0.00
EDAP TMS S.A (EDAP) France $0.122B 421.00
Restoration Robotics (VERO) Canada $0.095B 0.00
MRI Interventions (CLPT) United States $0.093B 0.00
Spectral Diagnostics (EDTXF) Canada $0.087B 0.00
Neuronetics (STIM) United States $0.079B 0.00
ConforMIS (CFMS) United States $0.061B 0.00
Bioanalytical Systems (BASI) United States $0.053B 0.00
Neovasc (NVCN) Canada $0.050B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.050B 0.00
Delcath Systems (DCTH) United States $0.043B 0.00
Sensus Healthcare (SRTS) United States $0.043B 0.00
Ekso Bionics Holdings (EKSO) United States $0.042B 0.00
Apollo Endosurgery (APEN) United States $0.035B 0.00
Avinger (AVGR) United States $0.030B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.025B 0.00
ReWalk Robotics (RWLK) Israel $0.024B 0.00
Allied Healthcare Products (AHPI) United States $0.023B 0.00
Second Sight Medical Products (EYES) United States $0.020B 0.00
Helius Medical Technologies (HSDT) United States $0.019B 0.00
Ra Medical Systems (RMED) United States $0.019B 0.00
ENDRA Life Sciences (NDRA) United States $0.016B 0.00
CHF Solutions (CHFS) United States $0.015B 0.00
Dynatronics (DYNT) United States $0.010B 0.00
Viveve Medical (VIVE) United States $0.009B 0.00
OBALON THERPTCS (OBLN) United States $0.007B 0.00
Lianluo Smart (LLIT) China $0.007B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00